about
Cardioprotection during cardiac surgeryImproving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: lost in translation?Gata4 and Sp1 regulate expression of the erythropoietin receptor in cardiomyocytesChronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.Did clinical trials in which erythropoietin failed to reduce acute myocardial infarct size miss a narrow therapeutic window?Impact of serum erythropoietin level on collateral vessel development in patients with coronary artery disease.A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage.High-dose erythropoietin in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized controlled trials.Acute hemodynamic effects of erythropoietin do not mediate its cardioprotective properties.Cardioprotective growth factors.Effect of Erythropoietin on Postresuscitation Renal Function in a Swine Model of Ventricular Fibrillation.Emerging technologies in the delivery of erythropoietin for therapeutics.Review of the role of erythropoietin in critical leg ischemia.Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework.Effect of erythropoiesis-stimulating agents in acute ST-segment elevation myocardial infarction: a systematic review.Pharmacological management of cardiorenal syndromes.Potential of Novel EPO Derivatives in Limb IschemiaSpeckle tracking imaging improves in vivo assessment of EPO-induced myocardial salvage early after ischemia-reperfusion in rats.Effect of recombinant human erythropoietin on mitomycin C-induced oxidative stress and genotoxicity in rat kidney and heart tissues.
P2860
Q26866366-C5225B10-5727-4A3B-90B7-E0BC63B26C26Q28069954-F8D8E854-D55E-4C0E-B99F-F9DB7AC64C80Q28587709-A1ABCA19-9F73-4CDE-80EB-D4C8FB82E2B7Q30539892-99B093F4-B0B8-4E43-9354-435A47C1BBEDQ31056941-7CCFDA9B-1A5D-46EE-9835-DBF303860B88Q33792006-A69D9225-C76D-4FF1-B2D0-E5319EAF848DQ34699514-6A12ACAE-21CB-49B0-8FC6-67AB14D2C3E5Q35008662-5211731E-7943-4296-BA88-75D0FEDF77E2Q36425514-83899AD9-4B20-49BC-8073-E1C4CAF4F0F8Q37393585-EB9538DB-36C7-4EA3-9924-A88CE19BF760Q37399494-73AD87E6-EAD0-4299-AC91-CF89F9C4B397Q37646523-9E52A36E-8669-4E4E-8D88-E860C7A6EE97Q37750097-BDFBCCAA-1434-43D3-9206-FB778F263FA4Q37907323-EF39ACB3-BF34-4AF8-9EEA-3E0E250B6CD0Q37956569-BE63C3D9-6AE6-48A3-BA96-048A741A37A3Q39740830-BE5F0463-0A52-4803-9A5E-5A07905540D6Q42593705-92B2D425-04B9-4577-827E-615F15C5CA37Q43110147-4A5AC23B-F728-4735-9F25-B24F6C447951Q46802695-E31F677D-8B73-4E43-805B-80224742B954
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Erythropoietin: ready for prime-time cardioprotection.
@en
Erythropoietin: ready for prime-time cardioprotection.
@nl
type
label
Erythropoietin: ready for prime-time cardioprotection.
@en
Erythropoietin: ready for prime-time cardioprotection.
@nl
prefLabel
Erythropoietin: ready for prime-time cardioprotection.
@en
Erythropoietin: ready for prime-time cardioprotection.
@nl
P1476
Erythropoietin: ready for prime-time cardioprotection.
@en
P2093
Niels P Riksen
P304
P356
10.1016/J.TIPS.2008.02.002
P577
2008-03-21T00:00:00Z